Search results

This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs

This quality standard covers diagnosing and managing stable angina in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Last updated

1 February 2017

Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid) and tocilizumab (RoActemra) for treating COVID-19.

Result type

Technology appraisal guidance

Last updated

26 February 2026

This document describes the framework for setting out a series of standards to support people using patient decision aids (PDAs) in assessing the usefulness and quality of a PDA. It will also be useful to those developing PDAs in enabling them to undertake a self-assessment of the quality of their tools and processes

your procurement team for advice on evaluating bids. You can base your criteria on the core service requirements. They are set out in...

Evidence-based recommendations on ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids in adults. This involves focusing high-intensity ultrasound energy at the fibroids through the skin of the abdomen.

Result type

HealthTech guidance

Published

24 July 2019

Evidence-based recommendations on olaparib (Lynparza) for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy in adults.

Result type

Technology appraisal guidance

Published

5 July 2023

Evidence-based recommendations on topotecan for treating recurrent and stage IVB cervical cancer in adults.

Result type

Technology appraisal guidance

Published

28 October 2009

Early value assessment (EVA) guidance on digitally enabled therapies for adults with depression.

Result type

HealthTech guidance

Last updated

14 January 2025

Evidence-based recommendations on acalabrutinib (Calquence) for treating chronic lymphocytic leukaemia in adults.

Result type

Technology appraisal guidance

Published

21 April 2021

Evidence-based recommendations on using liquid-based cytology for cervical screening in adults.

Result type

Technology appraisal guidance

Published

22 October 2003

This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.

Result type

Antimicrobial prescribing guideline

Published

11 February 2020

This guideline sets out an antimicrobial prescribing strategy for acute pyelonephritis (upper urinary tract infection) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

Result type

Antimicrobial prescribing guideline

Published

31 October 2018

This guideline covers diagnosing and managing first or recurrent upper or lower urinary tract infection (UTI) in babies, children and young people under 16. It aims to achieve more consistent clinical practice, based on accurate diagnosis and effective management. It does not cover babies, children and young people with urinary catheters in situ, neurogenic bladders, significant pre-existing urinary tract disorders (uropathies), underlying renal disease or immunosuppression, or recurrent UTI in sexually active girls and young women under 16. It also does not cover babies, children and young people in intensive care units.

Result type

NICE guideline

Published

27 July 2022

Evidence-based recommendations on irreversible electroporation (IRE) for treating renal cancer. This involves using electrical pulses to kill cancer cells, applied directly to the tumour through special needles.

Result type

HealthTech guidance

Published

23 February 2013